Friday, Apr 18 2025 | Time 17:47 Hrs(IST)
Business EconomyPosted at: Apr 11 2025 1:35AM


Granules India announces completion of 100 pc acquisition of Swiss-based Senn Chemicals

Hyderabad, Apr 10 (UNI) Granules India Limited on Thursday announced the successful acquisition of Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing.
This transaction also marks Granules’ foray into the CDMO space, with Senn’s established CDMO business providing a strong platform for growth. The acquisition enhances Granules’ global footprint and provides access to a regulated market client base and highly skilled scientific talent in Europe.
This marks a strategic milestone in Granules’ transformation into a science- and innovation-led organization and extends its capabilities into the fast-growing peptide therapeutics segment, the Hyderabad based pharma company said in a release here.
The acquisition follows the signing of a definitive share purchase agreement in February 2025, under which Granules, through its wholly owned Indian subsidiary, Granules Peptides Private Limited, acquired 100 percent of the equity of Senn Chemicals from the founding Senn family.
Senn Chemicals has built a strong reputation as a specialist in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), serving innovators and brand owners across pharmaceutical, cosmetic, amino acid derivative (AAD), and theragnostic markets.
The Senn Chemicals brand and its operations in Dielsdorf, Switzerland, will operate under Granules’ ownership, with a commitment to maintaining the company’s scientific excellence and customer focus.
Dr Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India, said, "The acquisition of Senn Chemicals AG marks a pivotal step in Granules’ strategic evolution into a science- and innovation-led organization. Together, we aim to drive meaningful impact in the complex therapeutics space."
The acquisition will enable Granules to accelerate development and manufacturing of GLP-1 receptor agonists and other peptide-based APIs, addressing the growing demand in anti-diabetic, anti-obesity, and other next-generation therapeutic areas.
Granules and Senn have already initiated joint development activities in this space, with a broader peptide API pipeline planned.
UNI KNR SS
Please log in to get detailed story.
Tags: #Granules India announces completion of 100 pc acquisition of Swiss-based Senn Chemicals
More News

Zydus Medtech partners with Braile Biomedica to commercialise TAVI technology

18 Apr 2025 | 3:16 PM

Mumbai, Apr 18 (UNI) Zydus MedTech Private Limited, a wholly owned subsidiary of Zydus Lifesciences Limited on Friday entered into a strategic partnership with Braile Biomédica Indústria, Comércio e Representações Ltda., (Braile Biomedica) - an innovative cardiovascular device manufacturer based in Brazil - to exclusively commercialise its Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and other select markets.

see more..

HDFC Securities posts robust financials

18 Apr 2025 | 2:59 PM

Kolkata, Apr 18 (UNI) HDFC Securities Limited reported exceptional performance for the financial year that ended on March 31, 2025, achieving a total income of Rs 3,265 crore, a robust 23 per cent increase from Rs 2,661 crore in the previous financial year.

see more..

Hyd: GHIAL operated Rajiv Gandhi International Airport Achieves Prestigious ACA Level 5 Carbon Accreditation

18 Apr 2025 | 1:41 PM

Hyderabad, Apr 18 (UNI) GMR Hyderabad International Airport Ltd (GHIAL) operated Rajiv Gandhi International Airport (RGIA) on Friday announced that it has been awarded the Level 5 Accreditation under the globally recognized Airport Carbon Accreditation (ACA) programme by Airports Council International (ACI).

see more..

Infosys fires 370 trainees despite ongoing govt probe: NITES

18 Apr 2025 | 1:39 PM

Bengaluru, Apr 18 (UNI) The Nascent Information Technology Employees Senate (NITES) has lodged a fresh and strongly-worded complaint with the Ministry of Skill Development and Entrepreneurship, accusing IT giant Infosys Ltd of carrying out the unlawful and unethical termination of 370 apprentices enrolled under the National Apprenticeship Training Scheme (NATS).

see more..
Capital India Finance Limited lists on NSE

Capital India Finance Limited lists on NSE

18 Apr 2025 | 1:08 PM

Mumbai, Apr 18 ( UNI) Capital India Finance Limited, a non-banking financial company, has announced its listing on the National Stock Exchange of India Limited ( NSE).

see more..